A
Atossa Therapeutics, Inc. Common StockATOS
Atossa Therapeutics, Inc. (Nasdaq: ATOS) is a clinical-stage biopharmaceutical company developing innovative medicines in oncology and other areas of significant unmet need. The Company's lead product candidate, (Z)-endoxifen, is currently in development across several clinical.
US StocksHealthcareSmall CapBiotechnology
ATOS の価格トレンド
Atossa Therapeutics, Inc. Common Stock · TradingView フルチャート
NASDAQ:ATOS